X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3605) 3605
Book Review (630) 630
Publication (145) 145
Newsletter (99) 99
Magazine Article (53) 53
Newspaper Article (41) 41
Conference Proceeding (7) 7
Trade Publication Article (7) 7
Book Chapter (6) 6
Dissertation (5) 5
Book / eBook (2) 2
Streaming Video (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3069) 3069
female (3025) 3025
humans (2998) 2998
levonorgestrel (2161) 2161
adult (1700) 1700
levonorgestrel - administration & dosage (1685) 1685
obstetrics & gynecology (1483) 1483
contraceptive agents, female - administration & dosage (818) 818
pregnancy (799) 799
adolescent (770) 770
women (726) 726
contraception (668) 668
levonorgestrel - adverse effects (662) 662
middle aged (610) 610
population (484) 484
intrauterine devices, medicated (472) 472
obstetrics and gynecology (461) 461
oral contraceptives (444) 444
abridged index medicus (420) 420
drug implants (410) 410
young adult (383) 383
ethinyl estradiol - administration & dosage (381) 381
birth control (366) 366
contraceptive agents, female - adverse effects (352) 352
levonorgestrel - pharmacology (339) 339
emergency contraception (328) 328
time factors (322) 322
levonorgestrel - therapeutic use (318) 318
contraceptives, oral, combined - administration & dosage (299) 299
prospective studies (299) 299
norgestrel - administration & dosage (295) 295
ethinyl estradiol (289) 289
treatment outcome (287) 287
reproductive biology (284) 284
contraceptive drug implants (272) 272
animals (249) 249
medicine, general & internal (236) 236
contraceptives (235) 235
pharmacology & pharmacy (226) 226
dosage and administration (221) 221
intrauterine devices, medicated - adverse effects (221) 221
male (221) 221
estradiol (213) 213
united states (210) 210
health aspects (209) 209
menorrhagia (208) 208
contraceptives, oral, combined - adverse effects (205) 205
risk factors (204) 204
intrauterine devices (201) 201
contraception - methods (199) 199
analysis (192) 192
risk (192) 192
follow-up studies (188) 188
endometrium - drug effects (183) 183
progesterone (183) 183
ethinyl estradiol - adverse effects (181) 181
estrogen (172) 172
oral-contraceptives (169) 169
contraceptives, oral, synthetic - administration & dosage (166) 166
efficacy (161) 161
endocrinology & metabolism (161) 161
menorrhagia - drug therapy (158) 158
research (158) 158
contraceptives, oral, combined - pharmacology (157) 157
pharmacokinetics (156) 156
public, environmental & occupational health (154) 154
administration, oral (153) 153
ethinyl estradiol - pharmacology (151) 151
desogestrel (150) 150
yuzpe regimen (150) 150
contraceptive agents, female - pharmacology (148) 148
menstruation (148) 148
progestins - administration & dosage (148) 148
usage (147) 147
endometrium (144) 144
mifepristone (144) 144
patient satisfaction (144) 144
norplant (140) 140
hormone replacement therapy (139) 139
levonorgestrel - pharmacokinetics (138) 138
contraceptive agents, female - therapeutic use (137) 137
drug administration schedule (137) 137
hysterectomy (136) 136
norgestrel - pharmacology (136) 136
device (134) 134
estradiol - blood (134) 134
estradiol - administration & dosage (133) 133
dose-response relationship, drug (129) 129
ethinylestradiol (127) 127
levonorgestrel intrauterine system (127) 127
levonorgestrel-releasing intrauterine system (127) 127
postmenopausal women (126) 126
delayed-action preparations (125) 125
norgestrel - adverse effects (125) 125
womens health (125) 125
ulipristal acetate (124) 124
progesterone congeners - administration & dosage (121) 121
contraception, postcoital - methods (120) 120
progesterone - blood (120) 120
intrauterine device (119) 119
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3638) 3638
French (44) 44
Chinese (34) 34
German (28) 28
Spanish (17) 17
Danish (7) 7
Polish (7) 7
Bulgarian (6) 6
Dutch (6) 6
Portuguese (6) 6
Russian (4) 4
Finnish (3) 3
Italian (3) 3
Japanese (3) 3
Swedish (3) 3
Croatian (2) 2
Czech (2) 2
Hungarian (2) 2
Norwegian (2) 2
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 09/2015, Volume 213, pp. 57 - 68
Women urgently need a self-initiated, multipurpose prevention technology (MPT) that simultaneously reduces their risk of acquiring HIV-1, HSV-2, and HPV... 
Efficacy | Core–matrix design | Contraception | Multipurpose prevention technology | Microbicides | Intravaginal ring | Core-matrix design | CLINICAL-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | CHEMISTRY, MULTIDISCIPLINARY | VAGINAL RING | TENOFOVIR DISOPROXIL FUMARATE | IN-VITRO | TYPE-2 INFECTION | COMBINATION MICROBICIDE | PHARMACOLOGY & PHARMACY | REVERSE-TRANSCRIPTASE INFECTION | HUMAN-PAPILLOMAVIRUS INFECTION | PROTECTS MACAQUES | Contraceptive Agents, Female - pharmacology | HIV Infections - prevention & control | Drug Delivery Systems - instrumentation | Antiviral Agents - pharmacokinetics | Urea - pharmacokinetics | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Contraceptive Agents, Female - administration & dosage | Pyridines - pharmacokinetics | Administration, Intravaginal | Human papillomavirus 16 - drug effects | Macaca mulatta | Equipment Design | Herpes Genitalis - prevention & control | Levonorgestrel - pharmacokinetics | Carrageenan - pharmacology | Urea - analogs & derivatives | Zinc Acetate - administration & dosage | Contraceptive Agents, Female - pharmacokinetics | Female | Herpesvirus 2, Human - drug effects | Urea - administration & dosage | Cell Line | Antiviral Agents - pharmacology | Levonorgestrel - pharmacology | Pyridines - administration & dosage | HIV-1 - drug effects | Carrageenan - pharmacokinetics | Contraceptive Devices, Female - virology | Antiviral Agents - administration & dosage | Pregnancy | Animals | Levonorgestrel - administration & dosage | Papillomavirus Infections - prevention & control | Zinc Acetate - pharmacokinetics | Zinc Acetate - pharmacology | Pyridines - pharmacology | HeLa Cells | Urea - pharmacology | Carrageenan - administration & dosage | Prevention | Contraceptives | Carrageenin | Pregnant women | Elastomers | Liquefied natural gas | HIV (Viruses) | Warships | Index Medicus | intravaginal ring | multipurpose prevention technology | core-matrix design | contraception | microbicides | efficacy
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, pp. e0182045 - e0182045
Combined estrogen-progestin preparations (CEPs) are associated with thromboembolic (TE) side effects. The aim of this study was to evaluate the incidence of TE... 
HORMONAL CONTRACEPTION | SYSTEM DATABASE | SIGNAL-DETECTION | VENOUS THROMBOEMBOLISM | MYOCARDIAL-INFARCTION | THROMBOSIS | ODDS RATIO | MULTIDISCIPLINARY SCIENCES | ORAL-CONTRACEPTIVE USE | SWEDISH WOMEN | RISK | Norgestrel - administration & dosage | Thromboembolism - chemically induced | Desogestrel - adverse effects | Humans | Middle Aged | Progestins - adverse effects | Male | Norgestrel - adverse effects | Estrogens - adverse effects | Norethindrone - administration & dosage | Young Adult | Ethinyl Estradiol - adverse effects | Drug-Related Side Effects and Adverse Reactions - genetics | Norethindrone - adverse effects | Adult | Female | Ethinyl Estradiol - administration & dosage | Contraceptives, Oral, Combined - administration & dosage | Odds Ratio | Child | Databases, Factual | Androstenes - adverse effects | Adverse Drug Reaction Reporting Systems | Japan | Androstenes - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Desogestrel - administration & dosage | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Progestins - administration & dosage | Adolescent | Estrogens - administration & dosage | Progestational hormones | Thromboembolism | Health aspects | Risk factors | Estrogen | Drugs | Ethinylestradiol | Medical equipment | Medical devices | Anemia | Estrogens | Cases (containers) | Risk analysis | Data mining | Patients | Estradiol | Data bases | Incidence | Birth control | Sex hormones | Side effects | Databases | Progestin | Health risk assessment | Pharmaceuticals | Index Medicus
Journal Article
International Journal of Clinical Pharmacology and Therapeutics, ISSN 0946-1965, 01/2015, Volume 53, Issue 1, pp. 41 - 53
Objective: Drug-drug interactions between canagliflozin, a sodium glucose co-transporter 2 inhibitor approved for the management of type-2 diabetes mellitus,... 
Warfarin | Oral contraceptive | Canagliflozin | Digoxin | Drug-drug interaction | LEVONORGESTREL | MANAGEMENT | VOLUNTEERS | PHARMACODYNAMICS | digoxin | warfarin | P-GLYCOPROTEIN | TRANSPORT | THERAPY | METABOLISM | canagliflozin | PHARMACOLOGY & PHARMACY | drug-drug interaction | oral contraceptive | EMPAGLIFLOZIN | Ethinyl Estradiol - blood | Anticoagulants - administration & dosage | Ethinyl Estradiol - pharmacokinetics | Thiophenes - adverse effects | Area Under Curve | Contraceptives, Oral, Combined - pharmacokinetics | Humans | Middle Aged | Half-Life | Male | Metabolic Clearance Rate | Thiophenes - administration & dosage | Healthy Volunteers | Warfarin - administration & dosage | Young Adult | Drug Dosage Calculations | Drug Interactions | Polypharmacy | Hypoglycemic Agents - administration & dosage | Levonorgestrel - pharmacokinetics | Adult | Female | Ethinyl Estradiol - administration & dosage | Contraceptives, Oral, Combined - administration & dosage | Digoxin - blood | Glucosides - adverse effects | Drug Administration Schedule | Risk Assessment | Sodium-Glucose Transporter 2 - metabolism | Cardiotonic Agents - pharmacokinetics | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Anticoagulants - blood | Digoxin - pharmacokinetics | Warfarin - pharmacokinetics | Cross-Over Studies | International Normalized Ratio | Cardiotonic Agents - administration & dosage | Blood Coagulation - drug effects | Digoxin - administration & dosage | Glucosides - administration & dosage | Cardiotonic Agents - blood | Levonorgestrel - administration & dosage | Levonorgestrel - blood | Warfarin - blood | Anticoagulants - pharmacokinetics | Hypoglycemic Agents - adverse effects | Contraceptives, Oral, Combined - blood | Index Medicus
Journal Article
Human Reproduction, ISSN 0268-1161, 9/2010, Volume 25, Issue 9, pp. 2256 - 2263
Journal Article